Yuyan Zhang
NHC Key Laboratory Of Microbial Drugs, State Key Laboratory Of Bioactive Substance And Function Of Natural Medicines, Chinese Academy Of Medical Sciences & Peking Union Medical College, Tiantan Xili 1#
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Novel aromatic amide Pan-PPAR agonists for dual amelioration of hepatic steatosis and islet dysfunction by promoting cholesterol efflux in the KKAy diabetic mice.
Journal: European journal of medicinal chemistry
Published: April 23, 2026
Novel SIRT1 up-regulator F1462 attenuates endothelial cell senescence and vascular aging by promoting mitochondrial biogenesis via activating the SIRT1/PGC-1α/TFAM pathway.
Journal: European journal of pharmacology
Published: April 03, 2026
A Novel RANKL/RANK Inhibitor IMB-R38 Inhibits Osteoporosis Through Regulating Bone Metabolism.
Journal: International journal of molecular sciences
Published: October 10, 2025
The novel small molecule E0924G dually regulates bone formation and bone resorption through activating the PPARδ signaling pathway to prevent bone loss in ovariectomized rats and senile mice.
Journal: Bioorganic chemistry
Published: January 14, 2024
A pan-PPAR agonist E17241 ameliorates hyperglycemia and diabetic dyslipidemia in KKAy mice via up-regulating ABCA1 in islet, liver, and white adipose tissue.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 13, 2023
SIRT1 Activator E1231 Alleviates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism.
Journal: Current issues in molecular biology
Published: April 21, 2023
Amplification-Free Detection of SARS-CoV-2 Down to Single Virus Level by Portable Carbon Nanotube Biosensors.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: December 28, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026